--
--(--)
--
--(--)
Expected P&L on Expiry
Key Stats
0.00DAY`S RANGE0.00
0.00
0.00
--
--
--
--
--
--
--
Pricing Model
--
--
--
--
--
--
About INSM20260220C170
Pharmaceutical
Insmed Incorporated is a biopharmaceutical company focused on developing inhaled therapies to combat life-threatening lung diseases for patients. The company's flagship products ARIKACE and amikacin liposome inhalation are an inhaled antibiotic therapy, proving that anti-infectives can improve the efficacy, safety and convenience of the therapy in the treatment of severe lung infections. The company was established in Commonwealth Virginia on November 29, 1999.
